Literature DB >> 7243844

Tolerance to anorectic drugs: pharmacological or artifactual.

D A Levitsky, B J Strupp, J Lupoli.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 7243844     DOI： 10.1016/0091-3057(81)90128-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN： 0091-3057            Impact factor:   3.533


× No keyword cloud information.
  10 in total

1.  Effects of nicotine on hunger and eating in male and female smokers.

Authors:  K A Perkins; L H Epstein; J E Sexton; R Solberg-Kassel; R L Stiller; R G Jacob
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  The Salmon lecture. Some perspectives on human obesity: treatment.

Authors:  A J Stunkard
Journal:  Bull N Y Acad Med       Date:  1988-11

Review 3.  Behavioural tolerance to amphetamine and other psychostimulants: the case for considering behavioural mechanisms.

Authors:  C Demellweek; A J Goudie
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  An analysis of behavioural mechanisms involved in the acquisition of amphetamine anorectic tolerance.

Authors:  C Demellweek; A J Goudie
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  Different behavioral mechanisms underlie tolerance to the anorectic effects of fenfluramine and quipazine.

Authors:  N Rowland; J Carlton
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet.

Authors:  Thomas A Wadden; Ken Fujioka; Soren Toubro; Ira Gantz; Ngozi E Erondu; Menghui Chen; Shailaja Suryawanshi; Wendy Carofano; Amy O Johnson-Levonas; Deborah R Shapiro; Keith D Kaufman; Steven B Heymsfield; John M Amatruda
Journal:  Obesity (Silver Spring)       Date:  2010-04-08       Impact factor: 5.002

7.  Sustained decreases in weight and serum insulin, glucose, triacylglycerol and cholesterol in JCR:LA-corpulent rats treated with D-fenfluramine.

Authors:  D N Brindley; P Hales; A I al-Sieni; J C Russell
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

8.  Blockade of body weight gain and plasma corticosterone levels in Zucker fatty rats using an orally active neuropeptide Y Y1 antagonist.

Authors:  Akane Ishihara; Akio Kanatani; Megumu Okada; Masayasu Hidaka; Takeshi Tanaka; Satoshi Mashiko; Akira Gomori; Tetsuya Kanno; Mikiko Hata; Maki Kanesaka; Yushin Tominaga; Naga-aki Sato; Masahiko Kobayashi; Takashi Murai; Keiko Watanabe; Yasuyuki Ishii; Takahiro Fukuroda; Takehiro Fukami; Masaki Ihara
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

9.  Effects of chronic phenylpropanolamine infusion and termination on body weight, food consumption and water consumption in rats.

Authors:  S E Winders; J C Amos; M R Wilson; P A Rushing; T Dykstra; M C Coday
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

10.  Performance and extinction of lever press behavior following chronic administration of desipramine to rats.

Authors:  I Lucki; A Frazer
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.